New and old oxazolidinones: tedizolid vs. linezolid

New and old oxazolidinones: tedizolid vs. linezolid

Tedizolid is a novel oxazolidinone that has been recently approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by Gram-positive pathogens, including MRSA. The mechanism of action of tedizolid is similar to other oxazolidinones – inhibition of bacterial pr...

Full description

Bibliographic Details
Main Authors:	Dekhnich A.V., Hachatryan N.N.
Format:	Article
Language:	Russian
Published:	Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2017-05-01
Series:	Клиническая микробиология и антимикробная химиотерапия
Subjects:	oxazolidinone tedizolid linezolid skin and skin structure infections staphylococcus mrsa
Online Access:	https://cmac-journal.ru/publication/2017/2/cmac-2017-t19-n2-p121/cmac-2017-t19-n2-p121.pdf

Similar Items

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections
by: Ferrández O, et al.
Published: (2016-12-01)

COMPARISON OF THE CLINICAL ACTIVITY OF TWO OXAZOLIDINONES – LINEZOLID AND TEDIZOLIDE: UNJUSTIFIED EXPECTATIONS
by: N. V. Dmitrieva, et al.
Published: (2018-11-01)

Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis
by: Shao-Huan Lan, et al.
Published: (2019-09-01)

Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
by: Alicia Rodríguez-Gascón, et al.
Published: (2021-06-01)

Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs
by: Eva Benavent, et al.
Published: (2021-01-01)

The Use of Oxazolidinone Products in the Treatment of Urinary Infections
by: D.D. Ivanov, et al.
Published: (2015-10-01)

Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials
by: Gregory J. Moran, et al.
Published: (2018-09-01)

Potential of the Introduction of Tedizolid for the Treatment of Complicated Skin and Soft Tissue Infections in a Russian Multi-Field Hospital
by: Belkova Yu.А., et al.
Published: (2016-08-01)

Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China
by: Shu’an Wen, et al.
Published: (2021-08-01)

Structure-Antibacterial Activity Relationships of N-Substituted-(d-/l-Alaninyl) 1H-1,2,3-Triazolylmethyl Oxazolidinones
by: Oludotun Adebayo Phillips, et al.
Published: (2018-09-01)

Tedizolid – a new antibiotic to solve old problems: prospects for the treatment of complicated skin and soft tissue infections
by: A. V. Rodin, et al.
Published: (2019-04-01)

Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient Setting
by: Ravina Kullar, et al.
Published: (2020-01-01)

Linezolid-induced black hairy tongue: a case report
by: Khasawneh Faisal Abdullah, et al.
Published: (2013-02-01)

Global Expansion of Linezolid-Resistant Coagulase-Negative Staphylococci
by: Vladimir Gostev, et al.
Published: (2021-09-01)

Oxazolidinone Antibiotics: Chemical, Biological and Analytical Aspects
by: Claudia Foti, et al.
Published: (2021-07-01)

Comparative Pharmacokinetic Study for Linezolid and Two Novel Antibacterial Oxazolidinone Derivatives in Rabbits: Can Differences in the Pharmacokinetic Properties Explain the Discrepancies between Their In Vivo and In Vitro Antibacterial Activities?
by: Mohsen A. Hedaya, et al.
Published: (2017-09-01)

Molecular characteristics of oxazolidinone resistance in enterococci from a multicenter study in China
by: Hongbin Chen, et al.
Published: (2019-07-01)

Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers
by: Shawn Flanagan, et al.
Published: (2018-06-01)

In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria
by: Sang-Hun Oh, et al.
Published: (2017-03-01)

Linezolid Resistant Enterococcus: An Important Emerging Pathogen Isolated from a Non Healing Ulcer of a Diabetic Foot Patient
by: Priya Datta, et al.
Published: (2017-12-01)

Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil
by: Helio S. Sader, et al.

Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil
by: Sader Helio S., et al.
Published: (2001-01-01)

Red Blood Cell Membrane-Camouflaged Tedizolid Phosphate-Loaded PLGA Nanoparticles for Bacterial-Infection Therapy
by: Xinyi Wu, et al.
Published: (2021-01-01)

Efficacy of linezolid against Staphylococcus aureus in different rodent skin and soft tissue infections models
by: Madhvi Rao, et al.
Published: (2011-07-01)

Optic neuropathy associated with linezolid: systematic review of cases
by: David Brandariz-Núñez, et al.
Published: (2019-03-01)

Linezolid as salvage therapy for central nervous system infections due to methicillin-resistant Staphylococcus aureus at two medical centers in Taiwan
by: Hong-An Chen, et al.
Published: (2020-12-01)

Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection
by: Timothy David Shaw, et al.
Published: (2021-08-01)

Evidence Associated with the Use of Oxazolidinones for the Treatment of Skin and Skin Structure Infections: A Retrospective Study
by: João Gonçalves-Pereira, et al.
Published: (2019-06-01)

Evidence Associated with the Use of Oxazolidinones in the Treatment of Skin and Skin Structure Infections: A Retrospective Study
by: Tiago Santos, et al.
Published: (2020-02-01)

Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity
by: Magdalena Paczkowska-Walendowska, et al.
Published: (2021-12-01)

Safety of long-term use of linezolid: results of an open-label study
by: Vazquez JA, et al.
Published: (2016-09-01)

Tedizolid activity against a multicentre worldwide collection of Staphylococcus aureus and Streptococcus pneumoniae recovered from patients with pneumonia (2017–2019)
by: Cecilia G. Carvalhaes, et al.
Published: (2021-06-01)

Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox® Antimicrobial Potency Study in Latin America (LA-ZAPS)
by: Charles H. Ballow, et al.

Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox® Antimicrobial Potency Study in Latin America (LA-ZAPS)
by: Ballow Charles H., et al.
Published: (2002-01-01)

Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection
by: Yu-Feng Zhou, et al.
Published: (2020-01-01)

Use of Linezolid in the treatment of surgical infectious complications under antibiotic resistance
by: O A Nazarchuk, et al.
Published: (2021-03-01)

The Use of Linezolid in the Treatment of Ventilator-Associated Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus
by: Büşra ERGÜT SEZER, et al.
Published: (2009-03-01)

Linezolid: a review of its properties, function, and use in critical care
by: Hashemian SMR, et al.
Published: (2018-06-01)

In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus
by: Weifeng Yang, et al.
Published: (2018-05-01)

Detection of a chromosomal truncated cfr gene in a linezolid-susceptible LA-MRSA ST398 isolate of porcine origin, Italy
by: Simona Fioriti, et al.
Published: (2021-09-01)

Cannot write session to /tmp/vufind_sessions/sess_gj7cmmu8p0vb6fvndi9enefol2